Related Experiment Video
Updated: May 22, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in
Galina E Morozevich1, Nadezda I Kozlova, Natalia A Ushakova
1V.N. Orekhovich Institute of Biomedical Chemistry RAMS, Moscow, Russia.
Abstract:
To delineate distinctive role of the components of α5β1 integrin-EGFR axis in control of epidermoid carcinoma cell proliferation, we performed individual inhibition of α5β1 and EGFR via genetic and phamacological methods, respectively. We demonstrated that pharmacological inhibition of epidermal growth factor receptor (EGFR) significantly affected proliferation of A431 human cells by inducing the G0/G1 cell cycle arrest, whereas shRNA-mediated depletion of α5 subunit of α5β1 integrin led to a similar type of cell cycle arrest followed by significant apoptosis. Both treatments resulted in suppression of activated (phosphorylated) forms of focal adhesion kinase (FAK) and Erk. However, unlike EGFR inhibition, depletion of α5 led to substantial suppression of AKT activity. Accordingly, pharmacological inhibition of EGFR and AKT recapitulated detrimental effects caused by shRNA-mediated depletion of α5. Moreover, depletion of α5 led to a severe drop in the amounts of active EGFR. Thus, for the first time, we demonstrated that α5β1 integrin simultaneously maintains pro-survival signaling via continuous activation of AKT and up-regulates proliferation via activation of EGFR.
Insights
The α5β1 integrin and epidermal growth factor receptor (EGFR) axis controls cancer cell growth. α5β1 integrin promotes survival via AKT and proliferation via EGFR, while EGFR inhibition alone causes cell cycle arrest.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- The α5β1 integrin and epidermal growth factor receptor (EGFR) axis plays a critical role in regulating cancer cell proliferation and survival.
- Understanding the distinct contributions of α5β1 integrin and EGFR is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To elucidate the specific roles of α5β1 integrin and EGFR in epidermoid carcinoma cell proliferation.
- To investigate the downstream signaling pathways affected by the inhibition of these components.
Main Methods:
- Genetic inhibition of the α5 subunit of α5β1 integrin using shRNA.
- Pharmacological inhibition of epidermal growth factor receptor (EGFR).
- Analysis of cell cycle progression, apoptosis, and key signaling molecules including FAK, Erk, AKT, and EGFR.
Main Results:
- EGFR inhibition induced G0/G1 cell cycle arrest in A431 cells.
- α5β1 integrin depletion caused G0/G1 arrest and apoptosis, suppressed AKT activity, and reduced active EGFR levels.
- Both treatments inhibited activated FAK and Erk, but only α5 depletion significantly impacted AKT and EGFR activity.
Conclusions:
- α5β1 integrin is essential for maintaining pro-survival signaling through AKT activation and for promoting proliferation via EGFR activation.
- Targeting α5β1 integrin offers a distinct therapeutic strategy by simultaneously affecting pro-survival and proliferative pathways, including EGFR and AKT.
Related Concept Videos
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway

